Company: VMCWF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001827
Chunk: 246

Company: Valuence Merger Corp. I
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 246
---
 and Continental Stock Transfer & Trust
Company, the letter agreement among us and our Initial Shareholders, officers, directors and director nominees, and the registration
rights agreement among us and our Initial Shareholders, may be amended without shareholder approval. These agreements contain various
provisions that our Public Shareholders might deem to be material. For example, the underwriting agreement related to the IPO contains
a covenant that the target company that we acquire must have a fair market value equal to at least 80% of the balance in the Trust Account
at the time of signing the definitive agreement for the transaction with such target business (excluding the deferred underwriting commissions
and taxes payable on the income earned on the Trust Account) so long as we obtain and maintain a listing for our securities on Nasdaq.
While we do not expect our Board of Directors to approve any amendment to any of these agreements prior to our initial Business Combination,
it may be possible that our Board of Directors, in exercising its business judgment and subject to its fiduciary duties, chooses to approve
one or more amendments to any such agreement in connection with the consummation of our initial Business Combination. Any such amendment
may have an adverse effect on the value of an investment in our securities.

Our
Public Warrants have been issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company,
as warrant agent, and us. The warrant agreement provides that the terms of the Public Warrants may be amended without the consent of
any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at least 50% of the
then outstanding Public Warrants to make any change that adversely affects the interests of the registered holders of Public Warrants.
Accordingly, we may amend the terms of the Public Warrants in a manner adverse to a holder if holders of at least 50% of the then outstanding
Public Warrants approve of such amendment. Although our ability to amend the terms of the Public Warrants with the consent of at least
50% of the then outstanding Public Warrants is unlimited, examples of such amendments could be amendments to, among other things, increase
the exercise price of the Public Warrants, shorten the exercise period or decrease the number of ordinary shares purchasable upon exercise
of a warrant.

The
Public Warrants may become exercisable and redeemable for a security other than the Class A ordinary shares, and you will not have any
information regarding such other security at this time.

In